In this Review:
Management of endocrine resistance:
The science behind the studies
• Professor Stephen Johnston (UK)
Current endocrine strategies in
metastatic breast cancer: Advantages
and practical limitations
• Professor Arlene Chan (Australia)
DEBATE: Targeted therapies and endocrine
treatments should be combined
upfront before endocrine resistance
can develop
• YES: Dr Javier Cortes (Spain)
• NO: Professor Stephen Johnston (UK)
Please login below to download this issue (PDF)